imatinib

Multi-slice spiral CT in evaluation of gastrointestinal stromal tumor treated with imatinib

多层螺旋CT评价伊马替尼治疗胃肠间质瘤疗效的价值

Application of imatinib in treatment of gastrointestinal stromal tumour

伊马替尼在胃肠道间质瘤治疗中的应用

OBJECTIVE To study and improve the synthesis of imatinib mesylate .

目的研究和改进甲磺酸伊马替尼的合成工艺。

Clinical Study of Chinese Gastrointestinal Stromal Tumors Patients Treated with Imatinib Mesylate

甲磺酸伊马替尼治疗国人胃肠间质瘤的临床研究

The Efficacy Analysis of Imatinib to the Chronic Myeloid Leukemia

Imatinib治疗慢性粒细胞性白血病的疗效分析

Long term regular monitoring of ABL kinase point mutation is necessary during imatinib treatment .

定期监测ABL激酶区点突变有助于及早采取干预治疗，提高疗效。

Efficacy and safety evaluation of imatinib in the treatment of 122 cases of chronic myeloid leukemia

甲磺酸伊马替尼治疗慢性粒细胞白血病122例疗效评价

Clinical observation on the effects of low dosage imatinib to chronic myelogenous leukemia in blast crisis

小剂量伊马替尼治疗慢性髓细胞白血病急变期患者的临床疗效

Imatinib mesylate in the treatment of advanced gastrointestinal stromal tumors

甲磺酸伊马替尼治疗51例晚期胃肠道间质瘤患者的疗效分析

Bone marrow morphologic features in patients treated with imatinib for Philadelphia chromosome positive chronic myeloid leukemia

伊马替尼治疗Ph阳性慢性粒细胞白血病引起的骨髓形态学变化

Imatinib mesylate inhibits bleomycin-induced pulmonary fibrosis in mice : the mechanism

甲磺酸伊马替尼抑制博莱霉素诱导小鼠肺纤维化的作用机制

Effect of proteasome inhibitor combined with imatinib on expression of livin mRNA in K562 cells

蛋白酶体抑制剂联合伊马替尼对K562细胞livin基因表达的影响

Apoptosis Effect of Imatinib on Primary Acute Megakaryocytic Leukemia Cells Expressing BCR / ABL

伊马替尼对BCR/ABL融合基因阳性的急性巨核细胞白血病原代细胞凋亡作用的研究

Imatinib mesylate alone for refractory advanced gastrointestinal stromal tumor

甲磺酸伊马替尼治疗复发或转移性胃肠间质瘤

For5 years , we followed patients with CMLwho received imatinib as initial therapy .

我们对接受伊马替尼作为初始治疗的CML患者进行了5年的随访。

Therapeutic concentrations of imatinib inhibits the activation and proliferation of normal T lymphocytes in vitro .

有效治疗浓度的伊马替尼在体外对T细胞增殖和活性有抑制作用。

Imatinib is currently the most popular therapy for chronic myeloid leukemia ( CML ) .

伊马替尼是目前治疗慢性髓细胞白血病的最普遍药物。

Imatinib in the treatment of metastatic and / or unresectable malignant gastrointestinal stromal tumors

Imatinib治疗转移性、不能手术切除的胃肠间质瘤

Evidence-Based Treatment of a Patient with Chronic-Phase Chronic Myeloid Leukemia by Imatinib

格列卫在1例慢性粒细胞白血病慢性期患者中的循证应用

The Experimental Investigation of Arsenic Trioxide Reverse Imatinib Mesylate Resistance in K562 / MDR1

三氧化二砷逆转甲磺酸伊马替尼对K562/MDR1耐药的实验研究

Drug reaction with eosinophilia and systemic symptoms ( DRESS ) following imatinib therapy ( Fren )

伊马替尼治疗后出现药物反应伴嗜酸性粒细胞增多症和系统症状（DRESS）（法语）

Objective To explore the inhibitory mechanism of Imatinib mesylate on pulmonary fibrosis induced by bleomycin in mice .

目的探讨格列卫对小鼠肺纤维化的干预机制。

Progression-free survival in gastrointestinal stromal tumours with high - dose imatinib : Randomised trial

应用高剂量伊马替尼的胃肠间质肿瘤患者的无进展生存期：随机试验

Detection of ABL point mutations in chronic myeloid leukemia patients treated with imatinib by denaturing high-performance liquid chromatography

应用变性高效液相色谱检测伊马替尼治疗后慢性髓性白血病患者ABL激酶区点突变

Imatinib in Combination with Chemotherapy in Treatment of BCR / ABL-Positive Acute Lymphoblastic Leukemia

伊马替尼联合化疗治疗初治BCR/ABL阳性急性淋巴细胞白血病的临床分析

Combination of Celecoxib and Imatinib has obviously synergistic effects in terms of anti-proliferation on K562 cells .

Celecoxib与伊马替尼联用，在抗白血病细胞增殖作用上具有显著的协同效应。

Monitoring bcr / abl mRNA levels in imatinib mesylate treated chronic myeloid leukemia patients by real-time quantitative RT-PCR

实时定量RT-PCR监测慢性粒细胞白血病患者伊马替尼治疗过程中bcr/AblmRNA水平

Pityriasis rosea - like eruption during treatment with imatinib mesylate : Description of 3 cases

甲磺酸伊马替尼治疗引发玫瑰糠疹样皮疹3例

Assessment of bcr / abl expression by real-time quantitative PCR in chronic myeloid leukemia patients after imatinib mesylate treatment

荧光定量PCR对伊马替尼治疗后慢性粒细胞白血病bcr/abl融合基因变化的检测效果研究

Application of interphase fluorescence in situ hybridization and sequencing analysis in imatinib treatment of patients with chronic myeloid leukemia in chronic phase

间期荧光原位杂交结合测序分析在慢性髓系白血病慢性期伊马替尼治疗监测中的应用